Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 10Insulin Resistance 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Leukoplakia, Oral 2Leukemia, Myeloid, Chronic-Phase 2Diabetes Mellitus, Type 2 2Carotid Intimal Medial Thickness 1 2Breast Neoplasms 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Pharmacokinetics of MDV3100 1Neoplasm Metastasis 1Multiple Myeloma 1Metabolic Syndrome 1Meningioma 1Memory Disorders 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Leukemia, Myeloid, Acute 1Inflammation 1Hyperinsulinism 1Head and Neck Neoplasms 1Glucose Intolerance 1

Interventions

Inositol 2relacorilant 1pembrolizumab 1maltodextrin 1Pioglitazone 1Metformin 1Liraglutide 1Leuprolide 1Inulin 1Estrogens 1Continuous Positive Airway Pressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Glucose Intolerance × Pioglitazone × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡